Skip to Content
 

News: Gastrointestinal Cancer

VUMC study sheds light on gastric cancer development

Thursday, January 16th, 2020

VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.

Colorectal cancer researchers receive SPORE funding

Saturday, August 31st, 2019

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Pancreatic cancer clue

Friday, August 30th, 2019

Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

Protein’s role in inflammation-related cancer studied

Friday, August 30th, 2019

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.

Vanderbilt team shows how stomach bug can trigger cancer

Thursday, July 11th, 2019

Researchers have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori to inject a cancer-causing protein into the stomach lining.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Eng named to GI cancer leadership position at VICC

Saturday, June 29th, 2019

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).

Receptor’s role in stopping H. pylori

Thursday, April 25th, 2019

A recent study demonstrates that loss of the receptor NOD1 augments inflammatory and injury responses to H. pylori – and points towards NOD1 as a prime target for modification for either preventing or treating H. pylori infections.

Major grant to bolster research on inflammation-related cancers

Thursday, January 24th, 2019

Cancer Research UK has awarded a 20-million-pound grant (about $26 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.

Philip’s liver cancer research receives V Foundation support

Friday, December 14th, 2018

Mary Philip, MD, PhD, has been named a 2019 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.

Next Page »